Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | thyroid stimulating hormone receptor | Starlite/ChEMBL | No references |
Homo sapiens | neuropeptide S receptor 1 | Starlite/ChEMBL | No references |
Homo sapiens | calcium channel, voltage-dependent, T type, alpha 1H subunit | Starlite/ChEMBL | No references |
Homo sapiens | GNAS complex locus | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Schistosoma mansoni | GTP-binding protein alpha subunit gna | GNAS complex locus | 394 aa | 450 aa | 28.7 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.0205 | 0.3543 | 0.7161 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0055 | 0.0812 | 0.2446 |
Plasmodium falciparum | isocitrate dehydrogenase [NADP], mitochondrial | 0.0033 | 0.0401 | 1 |
Mycobacterium tuberculosis | Probable isocitrate dehydrogenase [NADP] Icd1 (oxalosuccinate decarboxylase) (IDH) (NADP+-specific ICDH) (IDP) | 0.0033 | 0.0401 | 0.5 |
Echinococcus granulosus | tar DNA binding protein | 0.0193 | 0.332 | 0.332 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0055 | 0.0812 | 0.0812 |
Brugia malayi | calcium-independent alpha-latrotoxin receptor 2, putative | 0.0065 | 0.0989 | 0.2 |
Echinococcus granulosus | NADP dependent isocitrate dehydrogenase | 0.0033 | 0.0401 | 0.0401 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.0205 | 0.3543 | 0.7161 |
Echinococcus multilocularis | GPCR, family 2 | 0.0065 | 0.0989 | 0.0989 |
Brugia malayi | GTP-binding regulatory protein Gs alpha-S chain, putative | 0.0055 | 0.0812 | 0.1642 |
Schistosoma mansoni | NADP-specific isocitrate dehydrogenase | 0.0033 | 0.0401 | 0.1207 |
Echinococcus multilocularis | isocitrate dehydrogenase 2 (NADP+) | 0.0033 | 0.0401 | 0.0401 |
Toxoplasma gondii | isocitrate dehydrogenase | 0.0033 | 0.0401 | 1 |
Brugia malayi | Latrophilin receptor protein 2 | 0.0065 | 0.0989 | 0.2 |
Chlamydia trachomatis | DNA topoisomerase I | 0.0011 | 0 | 0.5 |
Echinococcus granulosus | diuretic hormone 44 receptor GPRdih2 | 0.0065 | 0.0989 | 0.0989 |
Chlamydia trachomatis | SWIB complex protein | 0.0011 | 0 | 0.5 |
Echinococcus multilocularis | tar DNA binding protein | 0.0193 | 0.332 | 0.332 |
Loa Loa (eye worm) | TAR-binding protein | 0.0193 | 0.332 | 0.6711 |
Loa Loa (eye worm) | follicle stimulating hormone receptor | 0.0283 | 0.4947 | 1 |
Leishmania major | isocitrate dehydrogenase [NADP], mitochondrial precursor, putative | 0.0033 | 0.0401 | 0.5 |
Onchocerca volvulus | 0.0011 | 0 | 0.5 | |
Trichomonas vaginalis | conserved hypothetical protein | 0.0208 | 0.3597 | 1 |
Schistosoma mansoni | tar DNA-binding protein | 0.0193 | 0.332 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0065 | 0.0989 | 0.2 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0055 | 0.0812 | 0.0812 |
Trypanosoma cruzi | isocitrate dehydrogenase, putative | 0.0033 | 0.0401 | 0.5 |
Echinococcus multilocularis | diuretic hormone 44 receptor GPRdih2 | 0.0065 | 0.0989 | 0.0989 |
Echinococcus multilocularis | isocitrate dehydrogenase | 0.0033 | 0.0401 | 0.0401 |
Loa Loa (eye worm) | RNA binding protein | 0.0193 | 0.332 | 0.6711 |
Schistosoma mansoni | tar DNA-binding protein | 0.0193 | 0.332 | 1 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0055 | 0.0812 | 0.0812 |
Echinococcus multilocularis | NADP dependent isocitrate dehydrogenase | 0.0033 | 0.0401 | 0.0401 |
Trypanosoma brucei | isocitrate dehydrogenase, putative | 0.0033 | 0.0401 | 0.5 |
Echinococcus multilocularis | cadherin EGF LAG seven pass G type receptor | 0.0065 | 0.0989 | 0.0989 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0055 | 0.0812 | 0.0812 |
Brugia malayi | follicle stimulating hormone receptor | 0.0283 | 0.4947 | 1 |
Plasmodium vivax | isocitrate dehydrogenase [NADP], mitochondrial, putative | 0.0033 | 0.0401 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.014 | 0.2361 | 0.4772 |
Brugia malayi | Isocitrate dehydrogenase | 0.0033 | 0.0401 | 0.081 |
Loa Loa (eye worm) | GTP-binding regulatory protein Gs alpha-S chain | 0.0055 | 0.0812 | 0.1642 |
Schistosoma mansoni | hypothetical protein | 0.0065 | 0.0989 | 0.298 |
Brugia malayi | RNA recognition motif domain containing protein | 0.0193 | 0.332 | 0.6711 |
Schistosoma mansoni | tar DNA-binding protein | 0.0193 | 0.332 | 1 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.0205 | 0.3543 | 0.7161 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0055 | 0.0812 | 0.2446 |
Schistosoma mansoni | hypothetical protein | 0.0065 | 0.0989 | 0.298 |
Brugia malayi | isocitrate dehydrogenase | 0.0033 | 0.0401 | 0.081 |
Echinococcus multilocularis | NADP dependent isocitrate dehydrogenase | 0.0033 | 0.0401 | 0.0401 |
Echinococcus granulosus | neuropeptide receptor A26 | 0.056 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0214 | 0.3704 | 0.7486 |
Echinococcus multilocularis | neuropeptide receptor A26 | 0.056 | 1 | 1 |
Schistosoma mansoni | hypothetical protein | 0.014 | 0.2361 | 0.7111 |
Brugia malayi | RNA binding protein | 0.0193 | 0.332 | 0.6711 |
Toxoplasma gondii | isocitrate dehydrogenase | 0.0033 | 0.0401 | 1 |
Echinococcus granulosus | GPCR family 2 | 0.0065 | 0.0989 | 0.0989 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.014 | 0.2361 | 0.4772 |
Trypanosoma cruzi | isocitrate dehydrogenase [NADP], mitochondrial precursor, putative | 0.0033 | 0.0401 | 0.5 |
Echinococcus multilocularis | neuropeptide s receptor | 0.056 | 1 | 1 |
Trypanosoma brucei | isocitrate dehydrogenase [NADP], mitochondrial precursor, putative | 0.0033 | 0.0401 | 0.5 |
Brugia malayi | Voltage-gated calcium channel, T-type, alpha subunit. C. elegans cca-1 ortholog | 0.0214 | 0.3704 | 0.7486 |
Schistosoma mansoni | hypothetical protein | 0.0065 | 0.0989 | 0.298 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0055 | 0.0812 | 0.2446 |
Loa Loa (eye worm) | RNA recognition domain-containing protein domain-containing protein | 0.0193 | 0.332 | 0.6711 |
Loa Loa (eye worm) | hypothetical protein | 0.0205 | 0.3543 | 0.7161 |
Loa Loa (eye worm) | latrophilin receptor protein 2 | 0.0065 | 0.0989 | 0.2 |
Schistosoma mansoni | tar DNA-binding protein | 0.0193 | 0.332 | 1 |
Brugia malayi | TAR-binding protein | 0.0193 | 0.332 | 0.6711 |
Schistosoma mansoni | hypothetical protein | 0.0065 | 0.0989 | 0.298 |
Echinococcus granulosus | cadherin EGF LAG seven pass G type receptor | 0.0065 | 0.0989 | 0.0989 |
Schistosoma mansoni | tar DNA-binding protein | 0.0193 | 0.332 | 1 |
Loa Loa (eye worm) | isocitrate dehydrogenase | 0.0033 | 0.0401 | 0.081 |
Echinococcus multilocularis | NADP dependent isocitrate dehydrogenase | 0.0033 | 0.0401 | 0.0401 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
EC50 (functional) | 0 uM | PUBCHEM_BIOASSAY: Inhibitors of T-Type Calcium Channel. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID449739, AID463087, AID493021, AID493022, AID493023, AID493041, AID504579, AID504584, AID504619, AID504628] | ChEMBL. | No reference |
Potency (functional) | 2.6169 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | = 10 um | PUBCHEM_BIOASSAY: qHTS Assay for Antagonists of the Neuropeptide S Receptor: cAMP Signal Transduction. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 11.2202 uM | PubChem BioAssay. qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 12.5893 um | PUBCHEM_BIOASSAY: qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 12.5893 um | PUBCHEM_BIOASSAY: qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor: Activators of Intracellular cAMP Concentrations in Parental HEK 293. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 14.1254 um | PUBCHEM_BIOASSAY: qHTS Assay for Small Molecule Inhibitors of Mitochondrial Division or Activators of Mitochondrial Fusion. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 18.3489 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of binding or entry into cells for Lassa Virus. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249] | ChEMBL. | No reference |
Potency (functional) | = 28.1838 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 31.6228 um | PUBCHEM_BIOASSAY: qHTS Fluorescence Polarization Assay for Inhibitors of MLL CXXC domain - DNA interaction. (Class of assay: confirmatory) [Related pubchem assays: 2698 (Summary assay.)] | ChEMBL. | No reference |
Potency (functional) | = 35.4813 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors and Activators of Human alpha-Galactosidase From Spleen Homogenate. (Class of assay: confirmatory) [Related pubchem assays: 1472, 1467 ] | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Plasmodium falciparum | ChEMBL23 | ||
Saccharomyces cerevisiae | ChEMBL23 | ||
Homo sapiens | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.